Gif-sur-Yvette, France

Catherine Guillou



 

Average Co-Inventor Count = 5.6

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 1999-2020

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Catherine Guillou

Introduction

Catherine Guillou is a prominent inventor based in Gif-sur-Yvette, France. She has made significant contributions to the field of medicinal chemistry, particularly in the development of therapeutic agents for various diseases. With a total of eight patents to her name, her work has garnered attention in the scientific community.

Latest Patents

Among her latest patents, Guillou has developed derivatives of indole for the treatment of cancer, viral infections, and lung diseases. These new classes of indole derivatives exhibit a specific MKlp2 inhibition profile, making them valuable as therapeutic agents. Her innovative approach aims to address critical health challenges associated with these diseases.

Career Highlights

Catherine has had a distinguished career, working with esteemed organizations such as the Centre National de la Recherche Scientifique and Biokinesis. Her research has not only advanced scientific knowledge but has also contributed to the development of potential treatments that could benefit patients worldwide.

Collaborations

Throughout her career, Guillou has collaborated with notable colleagues, including Claude Thal and Julien Rouleau. These partnerships have fostered a collaborative environment that enhances the quality and impact of her research.

Conclusion

Catherine Guillou's innovative work in the field of medicinal chemistry exemplifies her dedication to improving health outcomes through scientific research. Her contributions continue to inspire future advancements in the treatment of serious diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…